TRIVARION
Live / Registered — Registered and renewed (as of 11 Dec 2016)
What this means for you
Registered since 02 Oct 2007. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal was filed 28 Oct 2026 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 78918189
- Registration number
- 3304700
- Mark type
- Design + words
- Kind
- Trademark
- Register
- Principal
- Basis
- Use in commerce (§1(a))
- Filed
- 27 Jun 2006
- Published for opposition
- 20 Feb 2007
- Registered
- 02 Oct 2007
- Current term from
- 02 Oct 2017
- Next maintenance filing
- §8 & §9 renewal, filed 28 Oct 2026 — awaiting the USPTO's acceptance
- Examining attorney
- Christina B. King
- Attorney of record
- Suzann Moskowitz
Goods and services
- Class 010 — Medical apparatus: Transdermal drug delivery patches sold without medication
Owner
- NORTH COAST MEDICAL, INC., MORGAN HILL, CA, US
- ActivaTek, Inc., Salt Lake City, UT, US
- ActivaTek, Inc., Salt Lake City, UT, US
- ActivaTek, Inc., Salt Lake City, UT, US
Prosecution history
- 16 Nov 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 16 Nov 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Nov 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Nov 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Oct 2026 — TEAS SECTION 8 & 9 RECEIVED
- 02 Oct 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 19 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Nov 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 Dec 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 11 Dec 2016 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 11 Dec 2016 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED